Longevity9 min read·Published September 29, 2026

Why Mitochondrial DNA Matters for Energy, Inheritance, and Health

A plain-English guide to what mtDNA does, how it is inherited, and why it matters in disease and longevity research.

Why Mitochondrial DNA Matters for Energy, Inheritance, and Health

Mitochondrial DNA is important because it carries 37 genes needed for normal mitochondrial function, including genes that help cells make ATP, the body’s main usable energy. Changes in mtDNA can affect high-energy tissues such as the brain, muscles, heart, eyes, and inner ear, and mtDNA is usually inherited from the mother 1.

Not sure where to start? Take the 3-min clinical quiz.

See if you qualify →

Why is mitochondrial DNA important?

Mitochondrial DNA matters because its 37 genes help mitochondria run key parts of energy production. Even though mtDNA is tiny compared with nuclear DNA, changes in it can have a large effect because many tissues depend on steady energy supply 1.

Quick facts: mitochondrial DNA in plain English

Mitochondria are small structures inside cells that convert energy from food into a form cells can use. Most DNA is stored in the nucleus, but mitochondria have their own small genome called mitochondrial DNA, or mtDNA 1. For a starter guide, see our plain-English article on what mitochondrial DNA is.

The short answer: mtDNA helps cells make usable energy

The main job linked to mtDNA is support for oxidative phosphorylation, the process mitochondria use to make adenosine triphosphate, or ATP. ATP is the energy molecule cells use to power movement, signaling, repair, and normal organ function 1.

Why a small genome can have a large health impact

Human mtDNA spans about 16,500 base pairs, a small fraction of total cellular DNA. But it encodes parts of the electron transport chain, so problems in mtDNA can disrupt energy production in organs that need a lot of energy 1.

What does mitochondrial DNA do inside the cell?

mtDNA helps build core pieces of the machinery that turns food and oxygen into ATP. It does not work alone: mitochondrial function depends on close teamwork between mtDNA and genes in the nucleus 3.

How mtDNA supports oxidative phosphorylation

Oxidative phosphorylation is the oxygen-using process that helps create ATP. Thirteen mtDNA genes provide instructions for proteins used in this process, including parts of the electron transport chain 1. You can read more in our guide to what mitochondrial DNA does.

ATP: the energy molecule mtDNA helps cells produce

ATP is often described as the cell’s usable energy currency. When ATP supply drops, high-demand tissues may be more vulnerable because they need constant energy to work normally 1.

The 37 mitochondrial genes: 13 proteins, 22 tRNAs, and 2 rRNAs

Human mtDNA contains 37 genes. Thirteen code for oxidative phosphorylation proteins, 22 code for mitochondrial transfer RNAs, and 2 code for mitochondrial ribosomal RNAs, which help mitochondria assemble proteins 1.

mtDNA gene groupNumberMain role
Protein-coding genes13Help build oxidative phosphorylation and electron transport chain proteins
Transfer RNA genes22Help read genetic instructions during mitochondrial protein building
Ribosomal RNA genes2Help form mitochondrial ribosomes, the structures that assemble proteins

How is mitochondrial DNA different from nuclear DNA?

Mitochondrial DNA is small, circular, present in many copies per cell, and usually inherited from the mother. Nuclear DNA is packaged into linear chromosomes in the nucleus and contains most of the body’s genes 1.

Circular mtDNA vs linear nuclear chromosomes

Mitochondrial DNA is often described as a circular genome inside mitochondria. Nuclear DNA is organized into chromosomes inside the nucleus, and it makes up the large majority of a person’s DNA 1.

Many copies per cell vs two copies of most nuclear genes

Most nuclear genes are present as two copies, one from each biological parent. By contrast, cells can contain hundreds to thousands of mitochondria, and mitochondria can contain copies of mtDNA, so mtDNA copy number can vary by tissue and health state 1.

Why most mitochondrial proteins still come from nuclear DNA

Mitochondria need more than a thousand proteins to function, but mtDNA codes for only 13 proteins. Most mitochondrial proteins are encoded by nuclear DNA, made outside the mitochondria, and imported into mitochondria 3. For a side-by-side guide, see mitochondrial DNA vs nuclear DNA.

FeatureMitochondrial DNANuclear DNA
LocationInside mitochondriaInside the nucleus
Size in humansAbout 16,500 base pairsMuch larger genome across chromosomes
ShapeCircular genomeLinear chromosomes
Inheritance patternUsually maternalFrom both biological parents
Main role discussed hereEnergy-production machineryMost body traits and most mitochondrial proteins

How is mitochondrial DNA inherited?

mtDNA is usually inherited from the mother, which is why maternal family history matters in suspected mitochondrial disease. This pattern is not the same as inheritance for most nuclear genes, which come from both parents 2.

Why mtDNA is usually passed from the mother

Egg cells contribute most of the mitochondria to an embryo, while paternal mitochondria are generally not passed on. This is why mtDNA conditions can show a maternal inheritance pattern 2.

What mtDNA can and cannot tell you about ancestry

mtDNA can help trace maternal ancestry lines because it is usually passed through the mother. But ancestry results are not a diagnosis, and they do not tell the full story of health risk, because most traits involve nuclear genes, environment, and chance 2.

What heteroplasmy means and why mutation level can matter

Heteroplasmy means a person has a mix of mtDNA copies, some with a variant and some without it. The level of a disease-causing mtDNA change can vary between tissues, which helps explain why symptoms can differ between people and organs 2. Our deeper guide explains how mitochondrial DNA is inherited.

What health problems can involve mitochondrial DNA?

Mitochondrial DNA mutations can be involved in several recognized conditions, especially when high-energy tissues are affected. MedlinePlus lists conditions linked with mtDNA changes, including age-related hearing loss, cyclic vomiting syndrome, cytochrome c oxidase deficiency, Kearns-Sayre syndrome, and Leber hereditary optic neuropathy 1.

Why high-energy organs can be affected first

The brain, muscles, heart, eyes, and inner ear use a lot of energy. When mitochondrial energy production is impaired, these tissues may show symptoms because they have less room for an energy shortfall 1.

Examples: Leber hereditary optic neuropathy, Kearns-Sayre syndrome, cytochrome c oxidase deficiency, and age-related hearing loss

Leber hereditary optic neuropathy can cause central vision loss and is one of the best-known mtDNA-linked conditions. Kearns-Sayre syndrome, cytochrome c oxidase deficiency, age-related hearing loss, and cyclic vomiting syndrome are also listed by MedlinePlus as conditions associated with changes in mitochondrial DNA 1.

Human clinical evidence exists for some condition-specific therapies. For example, lenadogene nolparvovec gene therapy has been studied in Leber hereditary optic neuropathy, and elamipretide has been studied in primary mitochondrial myopathy; these trials are disease-specific and do not prove general lifespan extension 6, 7.

Why symptoms can vary between people and tissues

Symptoms can vary because different tissues may carry different levels of abnormal mtDNA, and because nuclear genes and environment also shape disease expression. This is one reason suspected mitochondrial disease often needs specialist evaluation rather than self-interpretation 2. See our overview of mitochondrial DNA and disease.

Why does mitochondrial DNA matter in aging and longevity research?

mtDNA integrity matters in longevity research because mtDNA damage, deletions, and copy-number changes are linked with aging-related disease biology. But a link to aging biology is not the same as proof that a treatment extends human lifespan 3.

Human evidence: mtDNA damage and copy-number changes are linked with aging-related disease biology

Human observational and mechanistic research links loss of mitochondrial genome integrity with severe early-onset mitochondrial disease and chronic age-related disease biology. Observational studies can show associations, but they cannot prove that changing an mtDNA marker will make a person live longer 3.

One human observational study measured circulating mtDNA markers in people with type 2 diabetes-related cognitive impairment. This kind of work can identify possible biomarkers, but it does not prove cause and effect or establish a treatment plan 8.

What animal and cell studies can show—and what they cannot prove

Animal and cell studies can help scientists test mechanisms, such as oxidative stress, reactive oxygen species, mtDNA deletions, and mitochondrial repair pathways. These studies are useful for discovery, but they do not prove longer human life or guarantee benefit in patients 3.

Why mtDNA research does not prove that any supplement or peptide extends human lifespan

At Chia, we cover longevity topics like mitochondrial therapy, NAD+, peptides, and cellular aging with careful labels for evidence type: human clinical, human observational, animal, or cell evidence. No supplement, peptide, or biomarker should be assumed to repair mitochondrial DNA, prevent mtDNA disease, or extend human lifespan unless that claim is directly proven in human outcomes research.

Can mitochondrial DNA affect medication response?

Pharmacogenomics researchers are studying whether mtDNA variation affects medication response, toxicity, or resistance. A systematic review found 24 studies from a defined search period, but the field was limited by mixed methods, limited replication, and small study power 4.

What pharmacogenomics researchers are studying

Pharmacogenomics asks why people respond differently to medicines. In mtDNA research, scientists have studied whether mitochondrial variants or haplogroups are linked with drug efficacy, side effects, or resistance, including antiretroviral, anticancer, and antimicrobial medicines 4.

Why current evidence is not yet strong enough for routine medication decisions in most people

The current evidence is promising but not strong enough for routine medication choices in most people. The systematic review noted heterogeneity, limited replication, and inadequate statistical power across many studies 4.

When genetic testing may be considered through a clinician or genetics specialist

Genetic testing may be considered when symptoms, family history, or specialist exam findings raise concern for a mitochondrial disorder. Medication decisions should be made with a clinician who can interpret the whole picture, not from ancestry data alone 2.

How do doctors evaluate possible mitochondrial DNA disorders?

Mitochondrial disease evaluation usually starts with symptoms, family history, exam findings, and targeted testing. Because symptoms can affect many organs, specialist referral is often important when a clinician suspects an inherited mitochondrial disorder 2.

When symptoms may prompt medical evaluation

Medical evaluation may be needed for unexplained muscle weakness, exercise intolerance, seizures, vision loss, hearing loss, heart rhythm issues, developmental concerns, or symptoms that affect several body systems. These symptoms do not always mean mitochondrial disease, but they deserve clinician review.

Genetic testing, family history, and specialist referral

A clinician may review maternal family history, examine affected organs, and consider genetic testing. In some cases, care may involve neurology, genetics, cardiology, ophthalmology, audiology, or metabolic specialists 2.

Why direct-to-consumer ancestry results are not a diagnosis

Direct-to-consumer ancestry testing can describe maternal lineage, but it is not the same as a medical-grade diagnostic workup. Results should not be used to diagnose or rule out mitochondrial disease without clinician review 2.

What is Chia’s role in mitochondrial and longevity education?

Chia provides education on mitochondrial biology and longevity research, but this article does not diagnose or treat mitochondrial DNA diseases. Our role here is to help you understand the science clearly and know when to seek medical care.

Education-only: Chia does not diagnose or treat mitochondrial DNA diseases through this article

Chia’s blog is not a genetics clinic, and this article is not a substitute for medical evaluation. If your concern is possible mitochondrial disease, a licensed clinician or genetics specialist is the right next step.

How Chia covers mitochondrial biology, NAD+, peptides, and longevity research without overstating the evidence

We write about mitochondrial biology, NAD+, peptides, cellular senescence, and longevity research with evidence labels. Human randomized trials, human observational studies, animal studies, and cell studies answer different questions; none should be blurred into a promise of longer human life.

Chia does offer some longevity-focused treatments, including NAD+, but we do not claim that any Chia product repairs mitochondrial DNA, prevents mtDNA disease, or extends human lifespan. Compounded medications are not FDA-approved, and any prescription through Chia requires an online health questionnaire and review by a licensed US provider; a prescription is never guaranteed.

When to seek medical care or genetic counseling instead of self-treating

Seek medical care if you have symptoms that are new, severe, progressive, or affecting several body systems. Seek genetic counseling if you have a known family history of mitochondrial disease, abnormal medical genetic testing, or questions about reproductive options such as preimplantation genetic diagnosis or mitochondrial replacement techniques 2.

FAQ: mitochondrial DNA importance

References

  1. 1.MedlinePlus Genetics. Mitochondrial DNA. U.S. National Library of Medicine. 2026.
  2. 2.National Academies of Sciences, Engineering, and Medicine. Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations. National Academies Press. 2016.
  3. 3.Saki M, Prakash A. DNA damage related crosstalk between the nucleus and mitochondria. Free Radical Biology and Medicine. 2017; and review: Mitochondrial DNA Integrity: Role in Health and Disease. International Journal of Molecular Sciences. 2019.
  4. 4.Jones R, et al. The Role of Mitochondrial DNA Variation in Drug Response. Pharmacogenomics and Personalized Medicine. 2021.
  5. 5.National Heart, Lung, and Blood Institute. Mitochondrial DNA Mutations in Heart, Lung and Blood Diseases. NIH Guide. 1996.
  6. 6.Karaa A, Bertini E, Carelli V, et al. Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial. Orphanet Journal of Rare Diseases. 2024.
  7. 7.Yu-Wai-Man P, Newman NJ, Biousse V, et al. Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy. JAMA Ophthalmology. 2025.
  8. 8.Silzer T, Barber R, Sun J, et al. Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans. PLOS ONE. 2019.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

Find what fits your body and your goals.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides